Member News

Notice to Hospitals: Health Canada Endorsed Important Safety Information on Busulfex® (busulfan) 6 mg/mL Injection

April 11, 2014

Please find a Notice to Hospitals recently issued by Otsuka Canada Pharmaceutical Inc. in consultation with Health Canada to inform Hospitals of a potential risk of black particulate matter in vials of Busulfex®

Read More

Next CBMTG Webinar: Wednesday, April 23, 2014

April 11, 2014

Wednesday, April 23, 2014 12:00pm ET/ 9:00am PT CME credit hours: 1.0 Topic: How can we use what we understand of GVHD biology to best treat chronic GVHD and augment GVL? Speaker: Dr. Kirk R. Schultz, MD

Read More

CBMTG 2014 Membership Now Available!

November 8, 2013

Membership for 2014 is now available. If you are a current member, please login with your username and password to the CBMTG website and follow the directions provided upon login. If you are not a current member, check out the benefits of membership by clicking on "join" in the above menu!

Read More

Intravenous Immune Globulin (IVIG) 2012 Audit Report

October 26, 2013

Please see here the ORBCON IVIG 2012 audit executive summary and full audit report

Read More
View All Member News